Pelvic Examination in Pregnancy (PEP)
Primary Purpose
Early Pregnancy Bleeding, Abdominal Pain
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
No Pelvic Exam
Pelvic Examination
Sponsored by
About this trial
This is an interventional other trial for Early Pregnancy Bleeding
Eligibility Criteria
Inclusion Criteria:
- Chief complaint of vaginal bleeding or lower abdominal pain
- Intra-uterine pregnancy seen on ultrasound
- Date < 16 weeks by estimated LMP or ultrasound
- Age >21
- Ability to provide written informed consent
- English speaking
Exclusion Criteria:
- Already enrolled in study
- Morbid Obesity (BMI > 40)
- Pelvic exam performed prior to ultrasound results
- Prisoner
- Follow up cannot be assured
- Admitted to hospital
- Large amount of vaginal bleeding (>10 pads in 24 hours or equivalent)
- Unstable vital signs (SBP<90 or HR>110)
- Known cervical carcinoma in the past 1 year
- Clinical suspicion for alternative syndrome that requires pelvic exam (such as severe pain consistent with ovarian torsion)
- Report or suspicion of penetrating vaginal trauma
- Suspicion of Active Labor
- Reported Sexual Assault
- Current pregnancy by IVF
- IUD in place
- Suspicion of heterotopic pregnancy on ultrasound
Sites / Locations
- Boston Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Pelvic Exam
No Pelvic Exam
Arm Description
Subjects receive pelvic exam
Subjects do not receive pelvic exam
Outcomes
Primary Outcome Measures
Composite Morbidity Endpoint
Adverse events include, but are not limited to, return visits to the Emergency Department, need for hospital admission, emergency procedure, transfusion, infection, or identification of other source of symptoms.
Secondary Outcome Measures
Patient Satisfaction
Throughput Time
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01570413
Brief Title
Pelvic Examination in Pregnancy
Acronym
PEP
Official Title
Utility of Pelvic Examination in the Evaluation of Threatened Abortion
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
February 2012 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study is designed to determine whether the pelvic examination (including bimanual and speculum examination) is necessary in patients with first trimester vaginal bleeding/ lower abdominal pain when an intra-uterine pregnancy (IUP) is seen on ultrasound. Patients with the chief complaint of vaginal bleeding or lower abdominal pain less than 16 weeks and positive HCG will be considered for this non-inferiority-designed clinical trial. All patients who present to the BMC Emergency Department (ED) Mon - Fri from 8am to 11pm and have had serum or urine HCG testing and a formal ultrasound by a credentialed emergency physician or radiology technician as part of standard of care will be screened for further eligibility. Those patients with intra-uterine pregnancies < 16 weeks gestation seen on ultrasound and meet inclusion criteria will then be asked to provide informed consent to participate in the study. Randomization will occur after consent has been obtained. Half of the patients will be randomized to receive pelvic examinations and the other half will not. Further care will be determined by the treating attending physician. The primary outcome will be a composite morbidity endpoint at 30 days, including return visits to the ED, emergency surgery, need for transfusion, infection, or other missed source of bleeding/ pain. Secondary outcomes of interest include ED throughput time, and patient satisfaction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Early Pregnancy Bleeding, Abdominal Pain
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
220 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pelvic Exam
Arm Type
Active Comparator
Arm Description
Subjects receive pelvic exam
Arm Title
No Pelvic Exam
Arm Type
Experimental
Arm Description
Subjects do not receive pelvic exam
Intervention Type
Procedure
Intervention Name(s)
No Pelvic Exam
Intervention Description
Will not receive pelvic examination.
Intervention Type
Procedure
Intervention Name(s)
Pelvic Examination
Intervention Description
Pelvic examination will be performed.
Primary Outcome Measure Information:
Title
Composite Morbidity Endpoint
Description
Adverse events include, but are not limited to, return visits to the Emergency Department, need for hospital admission, emergency procedure, transfusion, infection, or identification of other source of symptoms.
Time Frame
30 Days
Secondary Outcome Measure Information:
Title
Patient Satisfaction
Time Frame
24 Hours
Title
Throughput Time
Time Frame
24 Hours
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Chief complaint of vaginal bleeding or lower abdominal pain
Intra-uterine pregnancy seen on ultrasound
Date < 16 weeks by estimated LMP or ultrasound
Age >21
Ability to provide written informed consent
English speaking
Exclusion Criteria:
Already enrolled in study
Morbid Obesity (BMI > 40)
Pelvic exam performed prior to ultrasound results
Prisoner
Follow up cannot be assured
Admitted to hospital
Large amount of vaginal bleeding (>10 pads in 24 hours or equivalent)
Unstable vital signs (SBP<90 or HR>110)
Known cervical carcinoma in the past 1 year
Clinical suspicion for alternative syndrome that requires pelvic exam (such as severe pain consistent with ovarian torsion)
Report or suspicion of penetrating vaginal trauma
Suspicion of Active Labor
Reported Sexual Assault
Current pregnancy by IVF
IUD in place
Suspicion of heterotopic pregnancy on ultrasound
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Judith Linden, MD
Organizational Affiliation
Boston Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Boston Medical Center
City
Boston
State/Province
Massachusetts
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21691528
Citation
Brown J, Fleming R, Aristzabel J, Gishta R. Does pelvic exam in the emergency department add useful information? West J Emerg Med. 2011 May;12(2):208-12.
Results Reference
background
PubMed Identifier
17475104
Citation
Brown T, Herbert ME. Medical myth: Bimanual pelvic examination is a reliable decision aid in the investigation of acute abdominal pain or vaginal bleeding. CJEM. 2003 Mar;5(2):120-2. doi: 10.1017/s1481803500008289.
Results Reference
background
PubMed Identifier
15208231
Citation
Hoey R, Allan K. Does speculum examination have a role in assessing bleeding in early pregnancy? Emerg Med J. 2004 Jul;21(4):461-3. doi: 10.1136/emj.2003.012443.
Results Reference
background
PubMed Identifier
20002713
Citation
Isoardi K. Review article: the use of pelvic examination within the emergency department in the assessment of early pregnancy bleeding. Emerg Med Australas. 2009 Dec;21(6):440-8. doi: 10.1111/j.1742-6723.2009.01227.x.
Results Reference
background
PubMed Identifier
20159393
Citation
Seymour A, Abebe H, Pavlik D, Sacchetti A. Pelvic examination is unnecessary in pregnant patients with a normal bedside ultrasound. Am J Emerg Med. 2010 Feb;28(2):213-6. doi: 10.1016/j.ajem.2008.10.018.
Results Reference
background
Learn more about this trial
Pelvic Examination in Pregnancy
We'll reach out to this number within 24 hrs